Coronary Microvascular Dysfunction (CMD)
15
5
6
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (15)
Comprehensive Invasive Physiological Evaluation of Obstructive Coronary Artery Disease
PRECISE Phenotyping to Guide Therapies for Coronary Microvascular Dysfunction
iCorMicA - Stratified Medicine in Angina
Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective, Multicenter, Single-Group Target Value Study
CompREhensive Diagnostic Assessment of Coronary Endothelial Function Impairment and Vasospasm With CoNtinuous ThErmodilution in Patients With Suspected Coronary Microvascular and Vasomotor Dysfunction
The Correlation Between Obstructive Sleep Apnea-Related Nocturnal Hypoxemia Parameters and Coronary Microvascular Dysfunction: A Prospective Cohort Study (SLEEP-CMD)
The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease
Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)
Microvascular Coronary Rehabilitation For Improving Treatment - Feasibility Study
Inorganic Nitrate as a Treatment for ANOCA: NO-ANOCA
A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients.
INOCA-NA a Local Prospective Registry
Nebivolol ANOCA Treatment Randomized Trial
Prognostic Values of Coronary Microvascular Dysfunction Patients Treated with Rotational Atherectomy During Percutaneous Coronary Intervention
SHR Predicts CMD in Patients with CCS